Search Results
Dec 09, 2025, 11:57 ET Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
secured with Klothea Bio, Inc. The agreement grants the joint venture global rights to develop, manufacture, and commercialize Klothea Bio's proprietary Klotho-producing cells. These cells will be encapsulated using Austrianova's clinically validated Cell-in-a-Box® technology to
More news about: Equity Insider
Dec 09, 2025, 10:02 ET Former Under Secretary of the Navy Victor Minella Joins FedLearn Board of Advisors
build the training solutions that fit how sailors serve, learn and lead—securely, effectively and at the pace the mission demands."Review short bios of all the FedLearn board members at
More news about: FedLearn
Dec 09, 2025, 09:30 ET Reign Maker Talent Expands Portfolio & Welcomes Independent Firms, You Know Who and North House Talent
https://www.northhousetalent.com/Leadership BiosJoanna Giunta – Founder, You Know Who Formerly with Sports Illustrated Swimsuit and a leading talent agency, Giunta brings an
More news about: Reign Maker Group
Dec 09, 2025, 08:42 ET Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
an entirely new pathway for pharmaceuticals to effectively treat neurological disorders like Alzheimer's and Parkinson's. Perkins will join Mercury Bio's CSO, Richard Sayre Ph.D., and CEO, Bruce McCormick, in sharing more about the platform's unique capabilities at the upcoming Biotech Showcase in San
More news about: Mercury Bio Inc.
Dec 06, 2025, 09:45 ET Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual Meeting
candidate that uses T-cell–targeted lipid nanoparticles (T-LNPs) to deliver optimized mRNA encoding an anti-CD19 CAR. The platform integrates Grit Bio's proprietary CLAMP (Controllable Ligand Attachment Modification and Purification) technology, enabling site-specific antibody conjugation, precise ligand
More news about: Vivacta Biotechnology Co., Ltd.
Dec 04, 2025, 11:39 ET Immorta Bio Reports Reduction of Tumors in Validated Models of Lung, Brain, Pancreatic, and Breast Cancers Using Anti-Aging Vaccine "SenoVax™"
and StemCellRevivify™, a personalized cellular rejuvenation technology based on young organ-specific progenitor and mesenchymal stem cells. Immorta Bio's mission is to restore youthful biology, extend healthy lifespan, and treat the major diseases of aging through the integration of immunotherapy and
More news about: Immorta Bio Inc.
Dec 03, 2025, 09:05 ET Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research
novo protein design to create novel protein binders and biosensors for research use only (RUO) and in vitro diagnostic (IVD) applications. Monod Bio's proprietary AI platform enables the generation of novel proteins using in silico methods, including its NovoBody™ binders, to address unmet needs.
More news about: Monod Bio
Dec 03, 2025, 09:03 ET Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational Gonadotropin for Assisted Reproductive Technology
excited to participate in a study that has the potential to expand patient choice and increase access to care for those pursuing IVF."Granata Bio's gonadotropin program represents the company's continued commitment to innovation in fertility care, building on proven therapeutic classes while prioritizing
More news about: Granata Bio
Dec 02, 2025, 09:00 ET L&C Bio's 'Re2O' Emerges as a Leading K-Medical Tour Procedure Within One Year of Launch
multimedia:https://www.prnewswire.com/news-releases/lc-bios-re2o-emerges-as-a-leading-k-medical-tour-procedure-within-one-year-of-launch-302630313.htmlSOURCE
More news about: L&C BIO Co., Ltd
Dec 01, 2025, 07:00 ET Q32 Bio Sells Complement Inhibitor ADX-097
www.sec.gov. Any such risks and uncertainties could materially and adversely affect Q32 Bio's results of operations and its cash flows, which would, in turn, have a significant and adverse impact on Q32 Bio's stock price. Q32 Bio cautions you not to place undue reliance on any forward-looking statements,
More news about: Q32 Bio
Nov 27, 2025, 09:00 ET Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market
covering joint project development, exclusive representation in the Korean market, and global market expansion. This partnership leverages Sanyou Bio's globally leading AI-STAL drug discovery platform and FatiAbGen's deep local presence in South Korea to drive synergistic growth across Korea, Europe,
More news about: Sanyou Bio
Nov 25, 2025, 08:11 ET Immorta Bio Announces Publication of International Patent Application for SenoVax™, a First-in-Class Senolytic Immunotherapy
the publication of its international patent application PCT/WO2025184665[1], entitled "Senescence Vaccine." The application describes Immorta Bio's proprietary approach to stimulating the immune system to selectively eliminate senescent cells: the dysfunctional "old cells" that drive aging, inflammation,
More news about: Immorta Bio Inc.
Nov 24, 2025, 09:00 ET Save Big with ASUS this Holiday Season, Featuring Up to 40% Off a Wide Selection of Tech!
peace of mind.What sets it apart: Engineered with comprehensive ASUS ExpertGuardian security features, including a commercial-grade BIOS, Windows 11 Secured-core PC technologies, and a TPM 2.0 chip, the ASUS ExpertBook P5 creates a robust shield against daily digital threats. Enhanced
More news about: ASUS Computer International
Nov 24, 2025, 07:00 ET SuperX任命前Intel總經理Ken Lau為首席戰略官及執行董事，強化全球供應鏈佈局
地區先進製造能力的關鍵人物。深厚的英特爾背景與伺服器生態系建構經驗 在英特爾任職期間，Ken Lau先生曾作為英特爾台灣分公司總經理管理超過1,500人的團隊，並主導了將英特爾伺服器參考設計（Reference Design）的開發重心從美國轉移至台灣地區的策略舉措。他率先建立了亞太區資料中心工程與客戶支援體系，組建了一支涵蓋產品管理、硬體、韌體、BIOS、散熱、電源及市場行銷的全方位專家團隊。這一策略舉措不僅顯著最佳化了成本結構和系統整合效率，還成功擴大了單插槽及雙插槽Xeon™（至強）處理器的設計應用。在他的領導下，英特爾在台灣市場創下了97%的客戶滿意度。他極大地提升了系統整合效率與成本競爭力，並促成了
More news about: SuperX AI Technology Ltd
Nov 24, 2025, 07:00 ET SuperX、元IntelゼネラルマネージャーのKen Lau氏を最高戦略責任者（CSO）兼取締役に任命。グローバルサプライチェーン体制を強化
ーとして1,500人以上の専門家チームを統括し、インテルのサーバー向けリファレンスデザイン（Reference Design）の開発拠点を米国から台湾地区へ移行させる戦略的イニシアチブを主導しました。また、製品管理、ハードウェア、ファームウェア、BIOS、熱設計、電源、マーケティングを網羅する多分野の専門家チームを組織し、アジア太平洋地域におけるデータセンターエンジニアリングおよび顧客サポート体制をいち早く構築しました。この戦略的施策により、コスト構造とシステム統合（L10）効率が大幅に最適化されただけでなく、シング
More news about: SuperX AI Technology Ltd
Nov 24, 2025, 07:00 ET SuperX Appoints Former Intel GM Ken Lau as Chief Strategy Officer and Executive Director to Strengthen Global Supply Chain
Asia-Pacific data center engineering and customer support infrastructure, assembling a multidisciplinary team covering product management, hardware, firmware, BIOS, thermal, power, and marketing.This strategic initiative optimized cost structures and system integration efficiency
More news about: SuperX AI Technology Ltd
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
multimedia:https://www.prnewswire.com/news-releases/pepromene-bios-pmb-ct01-baffr-car-t-data-selected-for-two-oral-presentations-at-67th-ash-2025-annual-meeting-302621235.html
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
content:https://www.prnewswire.co.uk/news-releases/pepromene-bios-pmb-ct01-baffr-car-t-data-selected-for-two-oral-presentations-at-67th-ash-2025-annual-meeting-302621267.html
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 09:41 ET GitLab Foundation Strengthens Board of Directors With Leaders From Philanthropy, Outcomes-Focused System Transformation, Finance
the expanded board will be instrumental in helping the Foundation achieve its ambitious goals. Board bios: Caroline Whistler, Co-Founder and CEO, Third Sector: Brings expertise in advising government agencies
More news about: GitLab Foundation
Nov 20, 2025, 07:00 ET Evogene Reports Third Quarter 2025 Financial Results
included under the line titled: "Income (loss) from discontinued operations, net". This accounting presentation includes the sale of the majority of Lavie Bio's activity to ICL, which was completed in July 2025, and together with the sale of MicroBoost AI for Ag, generated income, net, of approximately $7.9
More news about: Evogene
Nov 18, 2025, 10:00 ET EvE Bio and DrugBank Partner to Bring Record-Scale Pharmome-Mapping Data to the Drug-Discovery Community
comprehensive dataset of drug-target interactions. Critically, EvE Bio's high-throughput process has been designed to produce a robust, verifiable datapoint for every potential interaction, whether active or inactive. EvE Bio's most recent data release (its seventh) brings the dataset
More news about: EvE Bio
Nov 18, 2025, 06:30 ET Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
novo protein design to create novel protein binders and biosensors for research use only (RUO) and in vitro diagnostic (IVD) applications. Monod Bio's proprietary platform enables the generation of novel proteins, including its NovoBody™ binders, to address unmet needs. Through its "Monod Inside" business
More news about: Bio-Techne Corporation
Nov 17, 2025, 17:31 ET Sepsis Market is Projected to Boost at a CAGR of 5.1% in the US During the Forecast Period (2025-2034) | DelveInsight
to immune-focused treatments, designed to enhance outcomes in sepsis care. VBI-S is Vivacelle Bio's leading Phase III therapeutic candidate for treating hypovolemic septic shock. Leveraging proprietary phospholipid nanoparticle technology, the drug
More news about: DelveInsight Business Research, LLP
Nov 14, 2025, 16:26 ET Amber F. McReynolds Re-Elected Chair of the Postal Service Board of Governors
expires on Dec. 8, 2028. He currently serves on the Board's Compensation and Governance Committee and the Operations Committee. Bios of all the governors are available at:
More news about: U.S. Postal Service
Nov 13, 2025, 15:08 ET Pivot Bio Expands Weatherproof Nitrogen Portfolio with New Dry Planter Box Treatments for Corn and Cotton
The new dry application delivers Pivot Bio's weatherproof nitrogen directly in the planter box, combining the same locked-in microbial nitrogen performance with a premium dry carrier that includes
More news about: Pivot Bio, Inc